Global Radiopharmaceutical Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at US$ 6871 million in 2024 and is forecast to a readjusted size of USD 11060 million by 2031 with a CAGR of 7.1% during review period.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiopharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales quantity, revenue, and global market share of Radiopharmaceutical from 2020 to 2025.
Chapter 3, the Radiopharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Radiopharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical.
Chapter 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiopharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Oncology
- Cardiology
- Other
- Cardinal Health
- GE Healthcare
- Jubilant Pharma
- Novartis
- Curium Pharma
- SIEMENS
- Lantheus
- Bracco Imaging
- Bayer
- Eli Lilly
- Aurobindo Pharma
- Mundipharma
- China Isotope & Radiation
- Dongcheng
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales quantity, revenue, and global market share of Radiopharmaceutical from 2020 to 2025.
Chapter 3, the Radiopharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Radiopharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical.
Chapter 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Radiopharmaceutical Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Diagnostic Radiopharmaceuticals
1.3.3 Therapeutic Radiopharmaceuticals
1.4 Market Analysis by Application
1.4.1 Overview: Global Radiopharmaceutical Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Other
1.5 Global Radiopharmaceutical Market Size & Forecast
1.5.1 Global Radiopharmaceutical Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Radiopharmaceutical Sales Quantity (2020-2031)
1.5.3 Global Radiopharmaceutical Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business
2.1.3 Cardinal Health Radiopharmaceutical Product and Services
2.1.4 Cardinal Health Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Cardinal Health Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Radiopharmaceutical Product and Services
2.2.4 GE Healthcare Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Jubilant Pharma
2.3.1 Jubilant Pharma Details
2.3.2 Jubilant Pharma Major Business
2.3.3 Jubilant Pharma Radiopharmaceutical Product and Services
2.3.4 Jubilant Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Jubilant Pharma Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Radiopharmaceutical Product and Services
2.4.4 Novartis Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Novartis Recent Developments/Updates
2.5 Curium Pharma
2.5.1 Curium Pharma Details
2.5.2 Curium Pharma Major Business
2.5.3 Curium Pharma Radiopharmaceutical Product and Services
2.5.4 Curium Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Curium Pharma Recent Developments/Updates
2.6 SIEMENS
2.6.1 SIEMENS Details
2.6.2 SIEMENS Major Business
2.6.3 SIEMENS Radiopharmaceutical Product and Services
2.6.4 SIEMENS Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SIEMENS Recent Developments/Updates
2.7 Lantheus
2.7.1 Lantheus Details
2.7.2 Lantheus Major Business
2.7.3 Lantheus Radiopharmaceutical Product and Services
2.7.4 Lantheus Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Lantheus Recent Developments/Updates
2.8 Bracco Imaging
2.8.1 Bracco Imaging Details
2.8.2 Bracco Imaging Major Business
2.8.3 Bracco Imaging Radiopharmaceutical Product and Services
2.8.4 Bracco Imaging Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Bracco Imaging Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Radiopharmaceutical Product and Services
2.9.4 Bayer Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Bayer Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Radiopharmaceutical Product and Services
2.10.4 Eli Lilly Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 Aurobindo Pharma
2.11.1 Aurobindo Pharma Details
2.11.2 Aurobindo Pharma Major Business
2.11.3 Aurobindo Pharma Radiopharmaceutical Product and Services
2.11.4 Aurobindo Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Aurobindo Pharma Recent Developments/Updates
2.12 Mundipharma
2.12.1 Mundipharma Details
2.12.2 Mundipharma Major Business
2.12.3 Mundipharma Radiopharmaceutical Product and Services
2.12.4 Mundipharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Mundipharma Recent Developments/Updates
2.13 China Isotope & Radiation
2.13.1 China Isotope & Radiation Details
2.13.2 China Isotope & Radiation Major Business
2.13.3 China Isotope & Radiation Radiopharmaceutical Product and Services
2.13.4 China Isotope & Radiation Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 China Isotope & Radiation Recent Developments/Updates
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceutical Product and Services
2.14.4 Dongcheng Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Dongcheng Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RADIOPHARMACEUTICAL BY MANUFACTURER
3.1 Global Radiopharmaceutical Sales Quantity by Manufacturer (2020-2025)
3.2 Global Radiopharmaceutical Revenue by Manufacturer (2020-2025)
3.3 Global Radiopharmaceutical Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Radiopharmaceutical Manufacturer Market Share in 2024
3.4.3 Top 6 Radiopharmaceutical Manufacturer Market Share in 2024
3.5 Radiopharmaceutical Market: Overall Company Footprint Analysis
3.5.1 Radiopharmaceutical Market: Region Footprint
3.5.2 Radiopharmaceutical Market: Company Product Type Footprint
3.5.3 Radiopharmaceutical Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Radiopharmaceutical Market Size by Region
4.1.1 Global Radiopharmaceutical Sales Quantity by Region (2020-2031)
4.1.2 Global Radiopharmaceutical Consumption Value by Region (2020-2031)
4.1.3 Global Radiopharmaceutical Average Price by Region (2020-2031)
4.2 North America Radiopharmaceutical Consumption Value (2020-2031)
4.3 Europe Radiopharmaceutical Consumption Value (2020-2031)
4.4 Asia-Pacific Radiopharmaceutical Consumption Value (2020-2031)
4.5 South America Radiopharmaceutical Consumption Value (2020-2031)
4.6 Middle East & Africa Radiopharmaceutical Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Radiopharmaceutical Sales Quantity by Type (2020-2031)
5.2 Global Radiopharmaceutical Consumption Value by Type (2020-2031)
5.3 Global Radiopharmaceutical Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Radiopharmaceutical Sales Quantity by Application (2020-2031)
6.2 Global Radiopharmaceutical Consumption Value by Application (2020-2031)
6.3 Global Radiopharmaceutical Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Radiopharmaceutical Sales Quantity by Type (2020-2031)
7.2 North America Radiopharmaceutical Sales Quantity by Application (2020-2031)
7.3 North America Radiopharmaceutical Market Size by Country
7.3.1 North America Radiopharmaceutical Sales Quantity by Country (2020-2031)
7.3.2 North America Radiopharmaceutical Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Radiopharmaceutical Sales Quantity by Type (2020-2031)
8.2 Europe Radiopharmaceutical Sales Quantity by Application (2020-2031)
8.3 Europe Radiopharmaceutical Market Size by Country
8.3.1 Europe Radiopharmaceutical Sales Quantity by Country (2020-2031)
8.3.2 Europe Radiopharmaceutical Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Radiopharmaceutical Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Radiopharmaceutical Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Radiopharmaceutical Sales Quantity by Type (2020-2031)
10.2 South America Radiopharmaceutical Sales Quantity by Application (2020-2031)
10.3 South America Radiopharmaceutical Market Size by Country
10.3.1 South America Radiopharmaceutical Sales Quantity by Country (2020-2031)
10.3.2 South America Radiopharmaceutical Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Radiopharmaceutical Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Radiopharmaceutical Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Radiopharmaceutical Market Drivers
12.2 Radiopharmaceutical Market Restraints
12.3 Radiopharmaceutical Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Radiopharmaceutical and Key Manufacturers
13.2 Manufacturing Costs Percentage of Radiopharmaceutical
13.3 Radiopharmaceutical Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Radiopharmaceutical Typical Distributors
14.3 Radiopharmaceutical Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Radiopharmaceutical Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Diagnostic Radiopharmaceuticals
1.3.3 Therapeutic Radiopharmaceuticals
1.4 Market Analysis by Application
1.4.1 Overview: Global Radiopharmaceutical Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Other
1.5 Global Radiopharmaceutical Market Size & Forecast
1.5.1 Global Radiopharmaceutical Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Radiopharmaceutical Sales Quantity (2020-2031)
1.5.3 Global Radiopharmaceutical Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business
2.1.3 Cardinal Health Radiopharmaceutical Product and Services
2.1.4 Cardinal Health Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Cardinal Health Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Radiopharmaceutical Product and Services
2.2.4 GE Healthcare Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Jubilant Pharma
2.3.1 Jubilant Pharma Details
2.3.2 Jubilant Pharma Major Business
2.3.3 Jubilant Pharma Radiopharmaceutical Product and Services
2.3.4 Jubilant Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Jubilant Pharma Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Radiopharmaceutical Product and Services
2.4.4 Novartis Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Novartis Recent Developments/Updates
2.5 Curium Pharma
2.5.1 Curium Pharma Details
2.5.2 Curium Pharma Major Business
2.5.3 Curium Pharma Radiopharmaceutical Product and Services
2.5.4 Curium Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Curium Pharma Recent Developments/Updates
2.6 SIEMENS
2.6.1 SIEMENS Details
2.6.2 SIEMENS Major Business
2.6.3 SIEMENS Radiopharmaceutical Product and Services
2.6.4 SIEMENS Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SIEMENS Recent Developments/Updates
2.7 Lantheus
2.7.1 Lantheus Details
2.7.2 Lantheus Major Business
2.7.3 Lantheus Radiopharmaceutical Product and Services
2.7.4 Lantheus Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Lantheus Recent Developments/Updates
2.8 Bracco Imaging
2.8.1 Bracco Imaging Details
2.8.2 Bracco Imaging Major Business
2.8.3 Bracco Imaging Radiopharmaceutical Product and Services
2.8.4 Bracco Imaging Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Bracco Imaging Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Radiopharmaceutical Product and Services
2.9.4 Bayer Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Bayer Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Radiopharmaceutical Product and Services
2.10.4 Eli Lilly Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 Aurobindo Pharma
2.11.1 Aurobindo Pharma Details
2.11.2 Aurobindo Pharma Major Business
2.11.3 Aurobindo Pharma Radiopharmaceutical Product and Services
2.11.4 Aurobindo Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Aurobindo Pharma Recent Developments/Updates
2.12 Mundipharma
2.12.1 Mundipharma Details
2.12.2 Mundipharma Major Business
2.12.3 Mundipharma Radiopharmaceutical Product and Services
2.12.4 Mundipharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Mundipharma Recent Developments/Updates
2.13 China Isotope & Radiation
2.13.1 China Isotope & Radiation Details
2.13.2 China Isotope & Radiation Major Business
2.13.3 China Isotope & Radiation Radiopharmaceutical Product and Services
2.13.4 China Isotope & Radiation Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 China Isotope & Radiation Recent Developments/Updates
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceutical Product and Services
2.14.4 Dongcheng Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Dongcheng Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RADIOPHARMACEUTICAL BY MANUFACTURER
3.1 Global Radiopharmaceutical Sales Quantity by Manufacturer (2020-2025)
3.2 Global Radiopharmaceutical Revenue by Manufacturer (2020-2025)
3.3 Global Radiopharmaceutical Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Radiopharmaceutical Manufacturer Market Share in 2024
3.4.3 Top 6 Radiopharmaceutical Manufacturer Market Share in 2024
3.5 Radiopharmaceutical Market: Overall Company Footprint Analysis
3.5.1 Radiopharmaceutical Market: Region Footprint
3.5.2 Radiopharmaceutical Market: Company Product Type Footprint
3.5.3 Radiopharmaceutical Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Radiopharmaceutical Market Size by Region
4.1.1 Global Radiopharmaceutical Sales Quantity by Region (2020-2031)
4.1.2 Global Radiopharmaceutical Consumption Value by Region (2020-2031)
4.1.3 Global Radiopharmaceutical Average Price by Region (2020-2031)
4.2 North America Radiopharmaceutical Consumption Value (2020-2031)
4.3 Europe Radiopharmaceutical Consumption Value (2020-2031)
4.4 Asia-Pacific Radiopharmaceutical Consumption Value (2020-2031)
4.5 South America Radiopharmaceutical Consumption Value (2020-2031)
4.6 Middle East & Africa Radiopharmaceutical Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Radiopharmaceutical Sales Quantity by Type (2020-2031)
5.2 Global Radiopharmaceutical Consumption Value by Type (2020-2031)
5.3 Global Radiopharmaceutical Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Radiopharmaceutical Sales Quantity by Application (2020-2031)
6.2 Global Radiopharmaceutical Consumption Value by Application (2020-2031)
6.3 Global Radiopharmaceutical Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Radiopharmaceutical Sales Quantity by Type (2020-2031)
7.2 North America Radiopharmaceutical Sales Quantity by Application (2020-2031)
7.3 North America Radiopharmaceutical Market Size by Country
7.3.1 North America Radiopharmaceutical Sales Quantity by Country (2020-2031)
7.3.2 North America Radiopharmaceutical Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Radiopharmaceutical Sales Quantity by Type (2020-2031)
8.2 Europe Radiopharmaceutical Sales Quantity by Application (2020-2031)
8.3 Europe Radiopharmaceutical Market Size by Country
8.3.1 Europe Radiopharmaceutical Sales Quantity by Country (2020-2031)
8.3.2 Europe Radiopharmaceutical Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Radiopharmaceutical Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Radiopharmaceutical Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Radiopharmaceutical Sales Quantity by Type (2020-2031)
10.2 South America Radiopharmaceutical Sales Quantity by Application (2020-2031)
10.3 South America Radiopharmaceutical Market Size by Country
10.3.1 South America Radiopharmaceutical Sales Quantity by Country (2020-2031)
10.3.2 South America Radiopharmaceutical Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Radiopharmaceutical Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Radiopharmaceutical Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Radiopharmaceutical Market Drivers
12.2 Radiopharmaceutical Market Restraints
12.3 Radiopharmaceutical Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Radiopharmaceutical and Key Manufacturers
13.2 Manufacturing Costs Percentage of Radiopharmaceutical
13.3 Radiopharmaceutical Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Radiopharmaceutical Typical Distributors
14.3 Radiopharmaceutical Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Radiopharmaceutical Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Radiopharmaceutical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 4. Cardinal Health Major Business
Table 5. Cardinal Health Radiopharmaceutical Product and Services
Table 6. Cardinal Health Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Cardinal Health Recent Developments/Updates
Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. GE Healthcare Major Business
Table 10. GE Healthcare Radiopharmaceutical Product and Services
Table 11. GE Healthcare Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GE Healthcare Recent Developments/Updates
Table 13. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Jubilant Pharma Major Business
Table 15. Jubilant Pharma Radiopharmaceutical Product and Services
Table 16. Jubilant Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Jubilant Pharma Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Radiopharmaceutical Product and Services
Table 21. Novartis Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Novartis Recent Developments/Updates
Table 23. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharma Major Business
Table 25. Curium Pharma Radiopharmaceutical Product and Services
Table 26. Curium Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Curium Pharma Recent Developments/Updates
Table 28. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 29. SIEMENS Major Business
Table 30. SIEMENS Radiopharmaceutical Product and Services
Table 31. SIEMENS Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SIEMENS Recent Developments/Updates
Table 33. Lantheus Basic Information, Manufacturing Base and Competitors
Table 34. Lantheus Major Business
Table 35. Lantheus Radiopharmaceutical Product and Services
Table 36. Lantheus Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Lantheus Recent Developments/Updates
Table 38. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 39. Bracco Imaging Major Business
Table 40. Bracco Imaging Radiopharmaceutical Product and Services
Table 41. Bracco Imaging Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Bracco Imaging Recent Developments/Updates
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Radiopharmaceutical Product and Services
Table 46. Bayer Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Bayer Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Radiopharmaceutical Product and Services
Table 51. Eli Lilly Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Aurobindo Pharma Major Business
Table 55. Aurobindo Pharma Radiopharmaceutical Product and Services
Table 56. Aurobindo Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Aurobindo Pharma Recent Developments/Updates
Table 58. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 59. Mundipharma Major Business
Table 60. Mundipharma Radiopharmaceutical Product and Services
Table 61. Mundipharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Mundipharma Recent Developments/Updates
Table 63. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 64. China Isotope & Radiation Major Business
Table 65. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 66. China Isotope & Radiation Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. China Isotope & Radiation Recent Developments/Updates
Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 69. Dongcheng Major Business
Table 70. Dongcheng Radiopharmaceutical Product and Services
Table 71. Dongcheng Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Dongcheng Recent Developments/Updates
Table 73. Global Radiopharmaceutical Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 74. Global Radiopharmaceutical Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Radiopharmaceutical Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 76. Market Position of Manufacturers in Radiopharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 77. Head Office and Radiopharmaceutical Production Site of Key Manufacturer
Table 78. Radiopharmaceutical Market: Company Product Type Footprint
Table 79. Radiopharmaceutical Market: Company Product Application Footprint
Table 80. Radiopharmaceutical New Market Entrants and Barriers to Market Entry
Table 81. Radiopharmaceutical Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Radiopharmaceutical Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Radiopharmaceutical Sales Quantity by Region (2020-2025) & (K Dose)
Table 84. Global Radiopharmaceutical Sales Quantity by Region (2026-2031) & (K Dose)
Table 85. Global Radiopharmaceutical Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Radiopharmaceutical Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Radiopharmaceutical Average Price by Region (2020-2025) & (USD/Dose)
Table 88. Global Radiopharmaceutical Average Price by Region (2026-2031) & (USD/Dose)
Table 89. Global Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 90. Global Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 91. Global Radiopharmaceutical Consumption Value by Type (2020-2025) & (USD Million)
Table 92. Global Radiopharmaceutical Consumption Value by Type (2026-2031) & (USD Million)
Table 93. Global Radiopharmaceutical Average Price by Type (2020-2025) & (USD/Dose)
Table 94. Global Radiopharmaceutical Average Price by Type (2026-2031) & (USD/Dose)
Table 95. Global Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 96. Global Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 97. Global Radiopharmaceutical Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Radiopharmaceutical Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Radiopharmaceutical Average Price by Application (2020-2025) & (USD/Dose)
Table 100. Global Radiopharmaceutical Average Price by Application (2026-2031) & (USD/Dose)
Table 101. North America Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 102. North America Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 103. North America Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 104. North America Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 105. North America Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 106. North America Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 107. North America Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 110. Europe Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 111. Europe Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 112. Europe Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 113. Europe Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 114. Europe Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 115. Europe Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 118. Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 119. Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 120. Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 121. Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2020-2025) & (K Dose)
Table 122. Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2026-2031) & (K Dose)
Table 123. Asia-Pacific Radiopharmaceutical Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Radiopharmaceutical Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 126. South America Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 127. South America Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 128. South America Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 129. South America Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 130. South America Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 131. South America Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 134. Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 135. Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 136. Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 137. Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 138. Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 139. Middle East & Africa Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Radiopharmaceutical Raw Material
Table 142. Key Manufacturers of Radiopharmaceutical Raw Materials
Table 143. Radiopharmaceutical Typical Distributors
Table 144. Radiopharmaceutical Typical Customers
Table 1. Global Radiopharmaceutical Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Radiopharmaceutical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 4. Cardinal Health Major Business
Table 5. Cardinal Health Radiopharmaceutical Product and Services
Table 6. Cardinal Health Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Cardinal Health Recent Developments/Updates
Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. GE Healthcare Major Business
Table 10. GE Healthcare Radiopharmaceutical Product and Services
Table 11. GE Healthcare Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GE Healthcare Recent Developments/Updates
Table 13. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Jubilant Pharma Major Business
Table 15. Jubilant Pharma Radiopharmaceutical Product and Services
Table 16. Jubilant Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Jubilant Pharma Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Radiopharmaceutical Product and Services
Table 21. Novartis Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Novartis Recent Developments/Updates
Table 23. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharma Major Business
Table 25. Curium Pharma Radiopharmaceutical Product and Services
Table 26. Curium Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Curium Pharma Recent Developments/Updates
Table 28. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 29. SIEMENS Major Business
Table 30. SIEMENS Radiopharmaceutical Product and Services
Table 31. SIEMENS Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SIEMENS Recent Developments/Updates
Table 33. Lantheus Basic Information, Manufacturing Base and Competitors
Table 34. Lantheus Major Business
Table 35. Lantheus Radiopharmaceutical Product and Services
Table 36. Lantheus Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Lantheus Recent Developments/Updates
Table 38. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 39. Bracco Imaging Major Business
Table 40. Bracco Imaging Radiopharmaceutical Product and Services
Table 41. Bracco Imaging Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Bracco Imaging Recent Developments/Updates
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Radiopharmaceutical Product and Services
Table 46. Bayer Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Bayer Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Radiopharmaceutical Product and Services
Table 51. Eli Lilly Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Aurobindo Pharma Major Business
Table 55. Aurobindo Pharma Radiopharmaceutical Product and Services
Table 56. Aurobindo Pharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Aurobindo Pharma Recent Developments/Updates
Table 58. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 59. Mundipharma Major Business
Table 60. Mundipharma Radiopharmaceutical Product and Services
Table 61. Mundipharma Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Mundipharma Recent Developments/Updates
Table 63. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 64. China Isotope & Radiation Major Business
Table 65. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 66. China Isotope & Radiation Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. China Isotope & Radiation Recent Developments/Updates
Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 69. Dongcheng Major Business
Table 70. Dongcheng Radiopharmaceutical Product and Services
Table 71. Dongcheng Radiopharmaceutical Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Dongcheng Recent Developments/Updates
Table 73. Global Radiopharmaceutical Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 74. Global Radiopharmaceutical Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Radiopharmaceutical Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 76. Market Position of Manufacturers in Radiopharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 77. Head Office and Radiopharmaceutical Production Site of Key Manufacturer
Table 78. Radiopharmaceutical Market: Company Product Type Footprint
Table 79. Radiopharmaceutical Market: Company Product Application Footprint
Table 80. Radiopharmaceutical New Market Entrants and Barriers to Market Entry
Table 81. Radiopharmaceutical Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Radiopharmaceutical Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Radiopharmaceutical Sales Quantity by Region (2020-2025) & (K Dose)
Table 84. Global Radiopharmaceutical Sales Quantity by Region (2026-2031) & (K Dose)
Table 85. Global Radiopharmaceutical Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Radiopharmaceutical Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Radiopharmaceutical Average Price by Region (2020-2025) & (USD/Dose)
Table 88. Global Radiopharmaceutical Average Price by Region (2026-2031) & (USD/Dose)
Table 89. Global Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 90. Global Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 91. Global Radiopharmaceutical Consumption Value by Type (2020-2025) & (USD Million)
Table 92. Global Radiopharmaceutical Consumption Value by Type (2026-2031) & (USD Million)
Table 93. Global Radiopharmaceutical Average Price by Type (2020-2025) & (USD/Dose)
Table 94. Global Radiopharmaceutical Average Price by Type (2026-2031) & (USD/Dose)
Table 95. Global Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 96. Global Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 97. Global Radiopharmaceutical Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Radiopharmaceutical Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Radiopharmaceutical Average Price by Application (2020-2025) & (USD/Dose)
Table 100. Global Radiopharmaceutical Average Price by Application (2026-2031) & (USD/Dose)
Table 101. North America Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 102. North America Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 103. North America Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 104. North America Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 105. North America Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 106. North America Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 107. North America Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 110. Europe Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 111. Europe Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 112. Europe Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 113. Europe Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 114. Europe Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 115. Europe Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 118. Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 119. Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 120. Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 121. Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2020-2025) & (K Dose)
Table 122. Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2026-2031) & (K Dose)
Table 123. Asia-Pacific Radiopharmaceutical Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Radiopharmaceutical Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 126. South America Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 127. South America Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 128. South America Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 129. South America Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 130. South America Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 131. South America Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2020-2025) & (K Dose)
Table 134. Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2026-2031) & (K Dose)
Table 135. Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2020-2025) & (K Dose)
Table 136. Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2026-2031) & (K Dose)
Table 137. Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2020-2025) & (K Dose)
Table 138. Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2026-2031) & (K Dose)
Table 139. Middle East & Africa Radiopharmaceutical Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Radiopharmaceutical Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Radiopharmaceutical Raw Material
Table 142. Key Manufacturers of Radiopharmaceutical Raw Materials
Table 143. Radiopharmaceutical Typical Distributors
Table 144. Radiopharmaceutical Typical Customers
LIST OF FIGURES
Figure 1. Radiopharmaceutical Picture
Figure 2. Global Radiopharmaceutical Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Radiopharmaceutical Revenue Market Share by Type in 2024
Figure 4. Diagnostic Radiopharmaceuticals Examples
Figure 5. Therapeutic Radiopharmaceuticals Examples
Figure 6. Global Radiopharmaceutical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Radiopharmaceutical Revenue Market Share by Application in 2024
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceutical Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Radiopharmaceutical Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Radiopharmaceutical Sales Quantity (2020-2031) & (K Dose)
Figure 14. Global Radiopharmaceutical Price (2020-2031) & (USD/Dose)
Figure 15. Global Radiopharmaceutical Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Radiopharmaceutical by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Radiopharmaceutical Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Radiopharmaceutical Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Radiopharmaceutical Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Radiopharmaceutical Average Price by Type (2020-2031) & (USD/Dose)
Figure 30. Global Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Radiopharmaceutical Revenue Market Share by Application (2020-2031)
Figure 32. Global Radiopharmaceutical Average Price by Application (2020-2031) & (USD/Dose)
Figure 33. North America Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 45. France Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Radiopharmaceutical Consumption Value Market Share by Region (2020-2031)
Figure 53. China Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 56. India Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 73. Radiopharmaceutical Market Drivers
Figure 74. Radiopharmaceutical Market Restraints
Figure 75. Radiopharmaceutical Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2024
Figure 78. Manufacturing Process Analysis of Radiopharmaceutical
Figure 79. Radiopharmaceutical Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Radiopharmaceutical Picture
Figure 2. Global Radiopharmaceutical Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Radiopharmaceutical Revenue Market Share by Type in 2024
Figure 4. Diagnostic Radiopharmaceuticals Examples
Figure 5. Therapeutic Radiopharmaceuticals Examples
Figure 6. Global Radiopharmaceutical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Radiopharmaceutical Revenue Market Share by Application in 2024
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceutical Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Radiopharmaceutical Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Radiopharmaceutical Sales Quantity (2020-2031) & (K Dose)
Figure 14. Global Radiopharmaceutical Price (2020-2031) & (USD/Dose)
Figure 15. Global Radiopharmaceutical Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Radiopharmaceutical by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Radiopharmaceutical Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Radiopharmaceutical Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Radiopharmaceutical Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Radiopharmaceutical Average Price by Type (2020-2031) & (USD/Dose)
Figure 30. Global Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Radiopharmaceutical Revenue Market Share by Application (2020-2031)
Figure 32. Global Radiopharmaceutical Average Price by Application (2020-2031) & (USD/Dose)
Figure 33. North America Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 45. France Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Radiopharmaceutical Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Radiopharmaceutical Consumption Value Market Share by Region (2020-2031)
Figure 53. China Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 56. India Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Radiopharmaceutical Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Radiopharmaceutical Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Radiopharmaceutical Consumption Value (2020-2031) & (USD Million)
Figure 73. Radiopharmaceutical Market Drivers
Figure 74. Radiopharmaceutical Market Restraints
Figure 75. Radiopharmaceutical Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2024
Figure 78. Manufacturing Process Analysis of Radiopharmaceutical
Figure 79. Radiopharmaceutical Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
